fbpx

Cannabis

GTEC Holdings (GTEC.C) CEO locks down the future, thumps chest on Twitter

GTEC Holdings (GTEC.C) is a company we’ve written about a lot, a BC-based cannabis grower that laid out a business model of multiple small licensed grow facilities, hitting the premium artisan weed market. Their products are great, their costs are low, and they’ve never yet benefited from the irrational weed booms of the ’15, ’16, and ’17 years because they were late to get those licenses.
This means, they’ve experienced all the weed industry dives, but none of the runs. Their stock price: $0.09, good for a market cap of just $11 million.

Read More »

Green Organic Dutchman (TGOD.T) drops fat quarterly loss, underwhelming revenues

No company in the Canadian cannabis space polarizes people like Green Organic Dutchman (TGOD.T), which roared to the public markets on perhaps the biggest promote yet seen, raised nine-digit totals along the way, swept in more first time private placement participants than any company before them, and then did… well… nothing, for a long time. With top brass having been walked recently and plans to super-size the company grow facilities shelved in the wake of underwhelming need for more weed, TGOD has made no secret it is at a moment of recalibration, but investors will have expected to see more than this.

Read More »

Heritage Cannabis (CANN.C) loses $2.3 million in Q4, finds extra year of runway as revenues kick in

A quick scan of headlines today would tell a harrowing story that Heritage Cannabis (CANN.C) was in big trouble and had lost $13 million and pandemonium had broken loose, and dogs and cats were going to be living together any time now. That’s because the company led their Q4 financials news release today with their yearly metrics filling the headlines, while their not-so-rough quarterly numbers were largely and inexplicably hidden from view.

Read More »

Invictus MD Strategies (GENE.V) kicked off Venture Exchange after screwing up everything for three years straight

Invictus MD Strategies (GENE.V) announced tonight that, in accordance with its efforts to work through creditor protection proceedings, it has been kicked off the Venture Exchange. On the upside, if Invictus’ history of going back on news releases is anything to go by, we’ll receive another release inside ten days that the bankruptcy proceedings have been cancelled and they’ll continue on as usual. Because that’s how it’s always been for Invictus, which has the worst track record in Canada’s cannabis space for announcing things, only to un-announce them very shortly after.

Read More »

2020 Gravitas Securities Growth Conference lines up seriously interesting deals, even in weed

Respect where it’s due, I haven’t been to an investor conference in a long time where I came away interested in most of what I saw, let alone *everything* I saw, but this year’s Gravitas Securities Growth Conference lineup absolutely hit it out of the park. The GSGC isn’t the biggest show around, but they know how to turn out the playahs, and the only way you keep big money showing up is to be a little bit picky with what you offer them. Don’t waste anyone’s time and they’ll know it’s cool to return.

Read More »

Wayland Group (WAYL.C) selling once hyped foreign assets for pennies on the dollar

As part of an ongoing process to deal with its bankruptcy, Wayland Group (WAYL.C) is dispensing with several foreign assets that were once touted as being amazing international opportunities, and it’s doing so at prices you can afford. The courts have granted approval for WAYL to get rid of its Colombian subsidiary, Colmed Pharmaceuticals, which was purchased in an all paper deal for 11 million shares a little over a year ago. Who’s buying it? It turns out, one of the companies that originally sold it to them, RG5 Investments.

Read More »

If the cannabis industry is desperate for capital, time to bet on the guys with capital

With a little over and hour left in the year 2019, past 10PM on December 31, I saw a news release from James E. Wagner Cultivation (JWCA.V) about a small $2 million loan they’d taken out. The timing of the announcement of their loan was surely not coincidental. Actually, thinking about it, ‘payday loan’ might be the more appropriate term to have used. JVCA took out a debenture financing of $2 million at an interest rate of 25% annually. That’s just the first tranche of the deal; there’s another $8 million out there if they want it. My credit card, abused as it has been, costs me less interest to maintain than JWCA’s loan.

Read More »

1933 Industries (TGIF.C) blows up, jumps 35% preceding California harvest announcement

You’ve gotta love it when a plan comes together: 1933 Industries (TGIF.C), which has been banging the same ‘we’re grownups, we’re doing it right, hang tight’ drum for several years now, dropped news this February 14 that will make any Valentine’s heart swell with joy. “Following the completion of a combined 20,000-square-foot expanded cultivation, extraction, manufacturing and distribution facility in the Los Angeles area, the company began harvesting its first cannabis crop this week to be utilized for both its proprietary brand Alternative Medicine Association (AMA), as well as for its licensing partner luxury brand Blonde cannabis, with products earmarked for dispensaries for the first time outside of Nevada.”

Read More »

Fire in the hole: Supreme Cannabis (FIRE.T) drops rough financials as expected, transition afoot

Ontario-based Supreme Cannabis (FIRE.T) released its Q2 2020 financials today and there were few surprises contained in its pages, bar perhaps the size of the quarterly loss. At a $17.3 million net loss after taxes (and a $10.4 million loss in adjusted EBITDA terms), FIRE shares fell in value below the $0.40 mark it’s been hovering around for some time, a 5% drop in real terms. Previous quarters had seen smaller losses, even come close to break even. But even the rosiest-eyed fanboy would have expected these numbers to be rough, considering the CEO change and staff layoffs announced earlier in the year.  We predicted as much a week ago.

Read More »

Hold your FIRE: Supreme Cannabis (FIRE.T) lays off staff in bid for balance sheet superiority

Large Canadian cannabis licensed producer Supreme Cannabis (FIRE.T) told the markets they’re laying off around 30% of their staff today, days before their next quarterly financials are released and with the dust still settling after their recent CEO change. To the casual observer, this might appear to be a sign of desperation, that the sky is falling in Kincardine, Ontario, and the owner of the esteemed 7 Acres brand was making some sort of last ditch effort to stave off Armageddon. It ain’t that.

Read More »

Vext Science (VEXT.C) cannabis chart defies gravity

“The core business, which is derived from an Arizona licensed vertically integrated model, generated USD $13 million in revenues during the first two quarters of 2019,” confirmed Equity Guru’s Sam Bourgi last October.

Ironically, VEXT is a healthy cannabis business, and investors are quickly gaining confidence in it.

Read More »

1933 Industries (TGIF.C) 2019 sales were 20% of its current market cap

Cannabis investors exhibit the same psychological characteristics as Dutch teenagers, a “volatile mix of anxiety, irritability, exuberance and despair.”

With teenagers, the irrational mood swings are due to “stress points around the uneasy transition toward adulthood.”

Cannabis investors don’t have this excuse.

Read More »

2019 weed wrap: The end of the cannabis cycle of cannabis cycles

Like the old Twilight Zone episode where helpful aliens leave behind a book called ‘To Serve Man’, only for us to find out later it’s a cookbook, investors have been welcomed and fattened up nicely by alpha predators as they unwittingly await their slaughter, not realizing that, they’re at the predator’s table because they’re the main course.

Read More »
Beleave-Kannabis.png

Equity.Guru podcast: Mistakes were made – Jeanette VanderMarel’s happy goodbye to Beleave (BE.C)

With the twitter announcement this morning that Jeanette had “happily” left the position of CEO at Beleave Kannabis (BE.C), Equity.Guru’s own Chris Parry was chomping at the bit to find out just what “happily” meant for the market and investors. Twenty minutes after making her announcement, VanderMarel phoned up Chris to give him the skinny on her decision as well as some explanations for past actions which gave both industry players and investors some pause.

Read More »

Deathwatch: MedMen (MMEN.C) is cutting out everything but the cancer that is killing it

If you’ve been around this joint for a while, you’ll have seen us arguing folks would be silly to invest in MedMen (MMEN.C) if hanging on to your money is a thing you aspire to do.

That’s not because we have a hate on for the dude-bros running the show, or because they’re not a client, or because we’re short sellers, or any of the other 50 or so reasons MedMen homers have thrown at us over the last few years as a rationale for us not seeing the company in the same rose-coloured way they do.

It’s because MedMen is, and has always been, shit.

Read More »

Equity Guru Podcasts